Literature DB >> 29563728

Aggressive Angioimmunoblastic T Cell Lymphomas (AITL) with Soft Tissue Extranodal Mass Varied Histopathological Patterns with Peripheral Blood, Bone Marrow, and Splenic Involvement and Review of Literature.

Tanushri Mukherjee1, Rajat Dutta2, S Pramanik2.   

Abstract

Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T cell non-Hodgkin lymphoma with an aggressive fatal course and it has varied clinical presentation with an uncommon presentation when they present as soft tissue masses or when there is spill in the peripheral blood or there are composite lymphomas that are rare presentations. Common presentations include lymphadenopathy, fever and systemic symptoms, hemolytic anemias, skin rashes, and rheumatoid arthritis. The classical histopathology is absence of follicles in lymph nodes with presence of high endothelial venules and the tumor cells of small to medium-sized lymphocytes with pale cytoplasm mixed with reactive T cells. On immunohistochemistry, the cells are positive for CD3, CD4, CD10, BCL2, and CXCL13. In this observational study, the clinicopathologic presentation and the immunohistochemical profile of five cases who initially presented with a soft tissue mass which is an extremely rare presentation of this rare type of non-Hodgkin lymphoma that was diagnosed at our center with peripheral blood and bone marrow involvement and the clinicopathologic presentation, immunohistochemical profile, and response to treatment on follow-up are correlated with the literature review. One case had a fulminant and aggressive course and was fatal within 2 months of diagnosis. The rest of the four cases are on regular chemotherapy and follow-up. Our five cases had presented with soft tissue masses, two in the axillary regio,n two in the hand, and one in the scapular region with an extranodal presentation, and there was associated lymphadenopathy which developed subsequently with classic histomorphology and immunohistochemical findings. The age range was 46-54 years and all five cases were males. Three cases were with anemia (hemoglobin range 6.5-8.0 mg/dl) and all five cases were having peripheral blood plasmacytosis. Histopathology was classic with paracortical involvement with polymorphous population of cells with neoplastic lymphocytes of small and large sizes with numerous arborizing blood vessels which correspond to high endothelial venules. Microscopically, three architectural patterns; pattern I was seen in three cases (60%) and then pattern II and III in one case each (20% each). Immunohistochemistry revealed CD4+, CD8-, CXCL13+, CD10+, BCL6+, CD19, CD20, CD1a, Tdt, CD21, and CD23+ in follicular dendritic cells. AITL is a rare and aggressive non-Hodgkin lymphoma with varied clinical presentation with classic histomorphology with various patterns which may cause diagnostic dilemma and immunophenotypic findings, and prompt and early diagnosis is mandatory for institution of therapy.

Entities:  

Keywords:  Angioimmunoblastic lymphoma; Non-Hodgkin lymphoma

Year:  2017        PMID: 29563728      PMCID: PMC5856684          DOI: 10.1007/s13193-017-0657-y

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  11 in total

1.  Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells.

Authors:  Jehan Dupuis; Karine Boye; Nadine Martin; Christiane Copie-Bergman; Anne Plonquet; Bettina Fabiani; Anne-Catherine Baglin; Corinne Haioun; Marie-Hélène Delfau-Larue; Philippe Gaulard
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

Review 2.  Angioimmunoblastic T-cell lymphoma.

Authors:  Emilio Iannitto; Andrés J M Ferreri; Viviana Minardi; Claudio Tripodo; Hans H Kreipe
Journal:  Crit Rev Oncol Hematol       Date:  2008-08-06       Impact factor: 6.312

3.  Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10.

Authors:  Ayoma Attygalle; Rajai Al-Jehani; Tim C Diss; Phillipa Munson; Hongxiang Liu; Ming-Qing Du; Peter G Isaacson; Ahmet Dogan
Journal:  Blood       Date:  2002-01-15       Impact factor: 22.113

4.  Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients.

Authors:  Florence Lachenal; Francoise Berger; Hervé Ghesquières; Pierre Biron; Arnaud Hot; Evelyne Callet-Bauchu; Catherine Chassagne; Bertrand Coiffier; Isabelle Durieu; Hugues Rousset; Gilles Salles
Journal:  Medicine (Baltimore)       Date:  2007-09       Impact factor: 1.889

Review 5.  Advances in the understanding and management of angioimmunoblastic T-cell lymphoma.

Authors:  Laurence de Leval; Christian Gisselbrecht; Philippe Gaulard
Journal:  Br J Haematol       Date:  2009-12-04       Impact factor: 6.998

6.  Clinicopathological analysis of a composite lymphoma containing both T- and B-cell lymphomas.

Authors:  Nobuko Suefuji; Daisuke Niino; Fumiko Arakawa; Kennosuke Karube; Yoshizo Kimura; Junichi Kiyasu; Masanori Takeuchi; Hiroaki Miyoshi; Maki Yoshida; Ayako Ichikawa; Yasuo Sugita; Koichi Ohshima
Journal:  Pathol Int       Date:  2012-10       Impact factor: 2.534

7.  Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers.

Authors:  Manuel Rodriguez-Justo; Ayoma D Attygalle; Phillipa Munson; Giovanna Roncador; Teresa Marafioti; Miguel A Piris
Journal:  Mod Pathol       Date:  2009-03-27       Impact factor: 7.842

8.  Angioimmunoblastic lymphadenopathy. Long-term follow-up study.

Authors:  G A Pangalis; E M Moran; B N Nathwani; R J Zelman; H Kim; H Rappaport
Journal:  Cancer       Date:  1983-07-15       Impact factor: 6.860

Review 9.  Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications.

Authors:  Kieron Dunleavy; Wyndham H Wilson; Elaine S Jaffe
Journal:  Curr Opin Hematol       Date:  2007-07       Impact factor: 3.284

10.  Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project.

Authors:  Massimo Federico; Thomas Rudiger; Monica Bellei; Bharat N Nathwani; Stefano Luminari; Bertrand Coiffier; Nancy L Harris; Elaine S Jaffe; Stefano A Pileri; Kerry J Savage; Dennis D Weisenburger; James O Armitage; Nicholas Mounier; Julie M Vose
Journal:  J Clin Oncol       Date:  2012-08-06       Impact factor: 44.544

View more
  1 in total

1.  Angioimmunoblastic T-cell lymphoma with exuberant plasmacytosis and spontaneous tumor lysis syndrome.

Authors:  Hafsa Faisal; Syed Ather Hussain; Rachel David; Stephen Silver
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-11-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.